Posts by Team VIVA!
VIVA! Communications celebrates Christmas French-style in the heart of The Rocks, Sydney – December 17, 2015
Team VIVA! celebrated the end of year in style yesterday by indulging in decadent French cuisine at Sydney’s glamorous, award-winning Ananas. Located in an historic building in the heart of The Rocks, team VIVA! enjoyed a scrumptious, three-course meal accompanied by flowing pink Moët & Chandon® , Secret Santa and other surprises.Throughout the afternoon, we…
Read MoreDoctor’s hit-back against $650m health budget cuts under Turnbull Government – December 17, 2015
The Federal Government released its Mid-Year Economic and Fiscal Outlook (MYEFO) figures on December 14, revealing a budget deficit for 2016-17 of $33.7 billion. To generate savings and offset the recent expenditure announced last week, Federal Health Minister, The Hon. Sussan Ley MP scrapped incentive payments that encouraged bulk billing of pathology services, such as…
Read MoreNurofen manufacturer in hot water by consumer watchdog following false claims regarding its painkillers – December 15, 2015
The manufacturer of Nurofen has been ordered to remove its targeted pain relief range from pharmacy and supermarket shelves following a Federal Court ruling that found consumers had been misled. The Australian Competition and Consumer Commission (ACCC) launched court action against Reckitt Benckiser In March , alleging Nurofen was misleading consumers by selling a range of…
Read MorePiping hot tea drinkers at potential risk of developing oesophageal cancer – December 10, 2015
Everyone loves a good cuppa, whether first thing in the morning, at noon or with supper. However, new research reveals that if you have a preference for scaldingly hot tea, you’re putting yourself at risk of oesophageal cancer. So how hot is hot? The new research was conducted in North Iran, a region that worships…
Read MoreOTC codeine rescheduling deferral at odds with rising harmful opioid misuse
The recent TGA decision to defer the rescheduling of codeine-containing OTC medications conflicts with rising codeine analgesics misuse, its devastating consequences and the recognition that opioid misuse is a public health concern. Further, the TGA’s own acknowledgement of low dose codeine efficacy, genetic variances in codeine metabolism and established misuse side-effects from combination OTC products, gives little…
Read More